Brief: Neogenomics Reports Third Quarter 2024 Results
Nov 5 (Reuters) - Neogenomics Inc NEO.O :
* NEOGENOMICS REPORTS THIRD QUARTER 2024 RESULTS
* : OUTLOOK FY CONSOLIDATED REVENUE $655 MILLION-$ 667
MILLION
* : QTRLY NET LOSS PER SHARE $0.14
* FY2024 REVENUE VIEW $661.7 MILLION -- LSEG IBES DATA
* Q3 EARNINGS PER SHARE VIEW $0.01 -- LSEG IBES DATA
Source text: ID:nBw1b9TwNa
Further company coverage: NEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring